Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 2Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Advanced Cancers 1

Interventions

Surveys and Questionnaires 3pazopanib 2Oxaliplatin 2Erlotinib Hydrochloride 2Cetuximab 2Bevacizumab 2satraplatin 1ixazomib 1Vorinostat 1Videotape Recording 1Valproic Acid 1Trastuzumab 1Platinum 1Leucovorin 1Lapatinib 1LY 2275796 1Fluorouracil 1Everolimus 1Capecitabine 1Azacitidine 1Albumin-Bound Paclitaxel 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Cancers × satraplatin × Clear all
NCT00473720 2013-01-23

Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers

Yale University

Phase 1 Completed
15 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡